| CAS NO: | 2072873-06-2 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 生物活性 | Sintilimab (IBI308) is a fully humanIgG4monoclonal antibody that binds toPD-1, thereby blocking the interaction ofPD-1with its ligands (PD-L1 and PL-L2) and consequently helping to restore the endogenous antitumour T-cell response. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lungcancerand oesophagealcancer[1]. |
| Clinical Trial | |
| 性状 | Liquid |
| CAS 号 | 2072873-06-2 |
| 中文名称 | 信迪利 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com